This session covers the recent discoveries from studies in experimental cholestasis models and results of clinical trials targeting the gut-liver axis. Several investigations in patients with inflammatory cholestatic disease, i.e., PSC or biliary atresia,

The recent advances in the cellular and geospatial immuno-genomic heterogeneity of cholangiocarcinoma may impact the future therapeutic approaches for this malignancy. Attendees will review the current and emerging strategies to manage the disease (i.e.,

Part 2: Pushing the envelope in liver transplantation

Part 2: Innovations in pediatric and young adult MASLD

Part 1: MASLD in pediatrics and young adults

Part 1: Epidemic of Severe Acute Hepatitis in Children: Epidemiology, Breakthroughs, and Future Response

Five 15-minute talks on the identified unmet needs in the management of PBC and PSC will be presented to attendees, followed by a multidisciplinary 15-minute Q&A discussion. Each speaker will review the current data on the topic and conclude with eith

Part 2: Hepatology meet Hematology: Can one live without the other?

Breakout C: Cirrhosis and  Liver Transplantation

Part 2: Liver Transplantation: New Frontiers in Liver Transplantation